F&V Capital Management’s Axogen AXGN Stock Holding History

F&V Capital Management’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.52M	Buy	184,385 +7,210	+4%	+$291K	1.57%	27
2026 Q1	$5.87M	Buy	177,175 +180	+0.1%	+$5.85K	1.24%	29
2025 Q4	$5.79M	Buy	+176,995	New	+$4.35M	1.23%	28

Other funds holding AXGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

F&V Capital Management's AXGN Position: Q2 2026 in Review

F&V Capital Management increased its Axogen (AXGN) stake by 4.1% in Q2 2026, buying an estimated $291K and bringing the position to 184,385 shares worth $8.52M. The position accounts for 1.57% of the portfolio, ranked #27.

F&V Capital Management first reported a position in AXGN in Q4 2025 and has held it in 3 quarters since. 254 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

F&V Capital Management held 184,385 shares of Axogen worth $8.52M as of Q2 2026.
F&V Capital Management bought 7,210 Axogen shares in Q2 2026, an estimated $291K.
Axogen made up 1.57% of F&V Capital Management's portfolio in Q2 2026, its #27 holding.
F&V Capital Management first reported a position in Axogen in Q4 2025 and has held it in 3 quarters since.
254 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on F&V Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.